Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 99,369 | 105,462 | 111,447 | 94,851 | 98,311 |
| Other current assets | 0 | 0 | 88 | 0 | 34 |
| TOTAL | $102,810 | $105,857 | $112,059 | $96,686 | $99,784 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 1 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1 |
| Total Assets | $102,810 | $105,857 | $112,059 | $96,686 | $99,785 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,608 | 562 | 1,839 | 3,157 | 1,584 |
| Accrued Expenses | 991 | 1,965 | 929 | 1,536 | 978 |
| TOTAL | $6,599 | $2,527 | $2,768 | $4,693 | $2,562 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,599 | $2,527 | $2,768 | $4,693 | $2,562 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,244 | 4,563 | 4,148 | 3,970 | 3,409 |
| Common Shares | 1 | N/A | N/A | N/A | 0 |
| Retained earnings | -351,914 | -336,110 | -325,263 | -314,855 | -308,588 |
| TOTAL | $96,211 | $103,330 | $109,291 | $91,993 | $97,223 |
| Total Liabilities And Equity | $102,810 | $105,857 | $112,059 | $96,686 | $99,785 |